11ÔÂ18ÈÕ ¹ú¼Ê½ðÈÚÔ籨
¹ú¼Ê½ðÈÚÊг¡
µÀÇí˹¹¤ÒµÆ½¾ù |
ÄÉ˹´ï¿Ë×ÛºÏ |
Ó¢¹úÂ׶ØFTSE |
µÂ¹ú·¨À¼¿Ë¸£DAX |
·¨¹ú°ÍÀèCAC40 |
11007.88 |
-15.62 |
2476.01 |
6.17 |
5692.56 |
10.66 |
6700.07 |
36.83 |
3792.35 |
29.88 |
°ÄÔª/ÃÀÔª |
Ó¢°÷/ÃÀÔª |
Å·Ôª/ÃÀÔª |
ÃÀÔª/ÈÕÔª |
ÃÀÔª/ÈËÃñ±Ò |
0.9798 |
0.0033 |
1.5899 |
0.0018 |
1.3521 |
0.0031 |
83.26 |
-0.01 |
6.6434 |
0.0048 |
CRB-R |
ÃÀÔªÖ¸Êý |
½üÔ»ƽð |
ŦԼÔÓͽüÔ |
²¨Â޵ĺ£¸É»õ |
295.43 |
-0.79 |
79.08 |
-0.13 |
1336.9 |
-1.5 |
80.44 |
-1.9 |
2188 |
-31 |
ÃÀ¹ÉÅ̺󩤾¼ÃÊý¾ÝÕý¸ºÏàµÖ Ò»ÈÕƽ¾² µÀָ΢´ì15.70µã
ÃÀ¹úͨ»õÅòÕͱ¨¸æÊý¾Ýά³Öκͣ¬¼õÇá·¿ÎÝÊг¡·Å»º´øÀ´µÄѹÁ¦£¬ÖÜÈý (17ÈÕ) ÃÀ¹ú¹ÉÊÐÊÕÅÌ΢·ùÕðµ´ÕûÀí£¬½ñÈÕÕûÈÕά³Öƽµ¡£
µÀÇí¹¤ÒµÆ½¾ùÖ¸Êý΢´ì 15.70 µã»ò 0.14% ÖÁ 11008 µã¡£
Nasdaq Ö¸ÊýСÕÇ 6.17 µã»ò 0.25% ÖÁ 2476 µã¡£
S&P 500 Ö¸ÊýÂÔÉý 0.25 µã»ò 0.02% ÖÁ 1179 µã¡£
·Ñ³Ç°ëµ¼ÌåÖ¸ÊýÏ»¬ 0.25 µã»ò 0.07% ÖÁ 373.82 µã¡£
µÀÇí¹¤ÒµÖ¸Êý³É·Ö¹ÉÖУ¬ÒԼҵñ¦ (Home Depot Inc)(HD-US) ºÍ»ÝÆÕ (Hewlett-Packard Co.£¬HP)(HPQ-US) µø·ù×îÖØ¡£µ«Âóµ±ÀÍ (McDonald's Corp.)(MCD-US)¡¢¿¨ÌرËÀÕ(Caterpillar Inc.)(CAT-US) ºÍ±£ÏÕÉÌ Travelers (TRV-US) µÄÇ¿¾¢±íÏÖ£¬ÓÐÖúÓÚ¹ÉÖ¸ÇúÏß»ØÕñ¡£
10 ÔÂÏû·ÑÕßÎï¼ÛÖ¸Êý (CPI) ÈԱƽüÀúʷе͵㣬²¿·Ö¾¼Ãѧ¼Ò±íʾ£¬Õâ´ú±íÃÀ¹úÁª×¼»á (Fed) ½«¼ÌÐø¶Ô¾¼ÃͶÈë½ðÈÚÔ®Öú¡£È»¶øÒ²ÓÐÈËÊ¿µ£ÓÇͨÅò¹ýµÍ£¬Fed µÄ¶¯×÷ÔÚÏÖ½ðÁ÷ÏòÉÌÆ·Êг¡Ê±£¬½«À¸ßÉÌÆ·¼Û¸ñ¡£
ING Investment Management ×ʲúÅäÖò¿×ܲà Paul Zemksy Ö¸³ö£º¡¸CPI Ä¿Ç°½Ó½ü 0%£¬Õâ²¢·ÇÎÒÃÇÄ¿Ç°ÀÖ¼ûµÄÇéÐΡ£¡¹
´ËÍ⣬±¾ÖÜÅ·ÖÞÕ®ÎñΣ»úÖØи¡ÉĮ̈Ã棬ÁîÐí¶àÊг¡Í¶×ÊÈË´ó¸ÐÕ𾪡£Å·ÔªÇø²ÆÕþ²¿³¤ºÍ¹ú¼Ê»õ±Ò»ù½ð (IMF) ¹ÙÔ±½ñÈÕÔÚ¶¼°ØÁÖ»áÃ棬ÉÌÌÖÈçºÎ´¦Àí°®¶ûÀ¼À§¶ÙµÄ¾¼Ã×´¿ö¡£
Key Private Bank Ê×ϯͶ×Ê·ÖÎöʦ Bruce McCain Éù³Æ£º¡¸¹ýÈ¥¼¸¸öÔÂÀ´£¬Êг¡ÆÈÇÐÏ£ÍûÖ÷ȨծÎñΣ»úµ»¯Ïûʧ£¬È»¶ø°®¶ûÀ¼ÀÆ𾯱¨£¬½«ÎÊÌâÖ±½ÓºáÔÚÑÛÇ°¡£¡¹
¾Àú 9-10 ÔÂÆÚ¼äµÄ»ý¼«ÕÇ·ùºó£¬Í¶×ÊÈËÈÏΪ 11 ÔµĹÉÊÐÏԵñ£ÊØ£¬²»ÁîÈ˸е½ÒâÍ⣬ÇÒĿǰȱ·¦ÕýÃæµÄ´ß»¯¼Á£¬ÒÔ¼°ÐµĽô±ÁѹÁ¦ÓÖÖØ»ØÊг¡¡£
×òÈÕÒòµ£ÓÇÅ·ÖÞºÍÖйúµÄ¾¼Ã·¢Õ¹£¬ÃÀ¹ú¹ÉÊдó·ùϵø£¬Èý´óÖ÷Òª¹ÉÖ¸µø·ù±Æ½ü 2%¡£
¾¼ÃÊý¾Ý£ºÃÀ¹úÀ͹¤²¿¹«²¼£¬ÃÀ¹ú 10 ÔÂÏû·ÑÕßͨ»õÅòÕÍÉÏÉýËÙ¶ÈÓÐËù¼õ»º¡£ÔÚÄÜÔ´¼Û¸ñÉÏÕÇ 2.6% µÄÍÆÉýÏ£¬ÃÀ¹ú 10 ÔÂÏû·ÑÕßÎï¼ÛÖ¸Êý (CPI) ÉÏÉý 0.2%¡£
¿Û³ýʳƷÓëÄÜÔ´£¬ÃÀ¹ú 10 ÔºËÐÄ CPI ³Öƽ£¬ÎªÁ¬ÐøµÚÈý¸öÔ³Öƽ¡£
ÃÀ¹úÉÌÎñ²¿½ñÈÕÐû²¼£¬ÃÀ¹ú 10 ÔÂÐÂÎÝ¿ª¹¤ÄêÂÊϽµ 11.7% ÖÁ 51.9 Íò¶°£¬´´ 18 ¸öÔµ͵㣬±íÏÖ²»ÈçÊг¡Ô¤ÆÚ£¬µ«ÐÂÎÝ¿ª¹¤Ðí¿ÉÔòС·ùÉÏÉý¡£
´ËÍ⣬9 ÔÂÐÂÎÝ¿ª¹¤ÂÊÓÉ 60 Íò¶°ÍùÏÂÐÞÕýÖÁ 58.8 Íò¶°¡£
ÆóÒµÏûÏ¢£º´¢´æ¼¼Êõ¹«Ë¾ NetApp Inc (NTAP-US) ·¢²¼µÚ 3 ¼¾²Æ±¨£¬»ñÀûÿ¹É 52 ÃÀ·Ö£¬ÓªÊÕ´ï 12 ÒÚÃÀÔª£¬±íÏÖÂÔÓÅÓÚ·ÖÎöʦ¹ÀÖµ¡£NetApp ½ñÈչɼÛÊÕÅÌ´ìµÍ 6.53% ÖÁ 49.25 ÃÀÔª£¬È»Å̺ó»ØÕÇ 1.32%¡£
ÃÀ¹úµÚ¶þ´óÕÛ¿ÛÉÌ Target (TGT-US) ±íʾ£¬µÚÈý¼¾»ñÀûÉÏÉý 23% ÖÁ 5.35 ÒÚÃÀÔª£¬»òÿ¹É 74 ÃÀ·Ö£¬ÓÅÓÚÊг¡Ô¤ÆÚ¡£È¥ÄêͬÆÚΪ 4.36 ÒÚÃÀÔª£¬»òÿ¹É 58 ÃÀ·Ö¡£ÏúÊÛÉÏÉý 3% ÖÁ 152 ÒÚÃÀÔª£¬Í¬µêÏúÊÛÑïÉý 1.6%¡£
Target ÊÕÅ̹ɼÛÉÏÕÇ 3.88% ÖÁ 55.62 ÃÀÔª¡£
È«Çò×î´óоƬÉú²úÉ豸ÖÆÔìÉÌÓ¦ÓòÄÁÏ (Applied Materials Inc.)(AMAT-US) ÔÚ½ñÈÕÅ̺󽫹«²¼µÚ 3 ¼¾²Æ±¨£¬·ÖÎö»ú¹¹ Thomson Reuters ר¼Ò¹À¼Æ£¬Æä»ñÀûµ±ÎªÃ¿¹É 31 ÃÀ·Ö¡£Ó¦ÓòÄÁϹɼÛÊÕµø 0.64% ÖÁ 12.38 ÃÀÔª¡£
ͨÓÃÆû³µ (General Motor) µÄÊ״ι«¿ªÄ¼¹É (IPO) ¹æÄ££¬½ñÈÕÔöÖÁ 4.78 ÒÚµµÆÕͨ¹É£¬ÕûÌ弯×ʽð¶îÒ²Éϳ嵽½«½ü 200 ÒÚÃÀÔª¡£¹À¼ÆÉÔÍí½«Õýʽ¹«²¼Ä¼¹ÉÏûÏ¢¡£
ÊÀ½çÊг¡£ºÅ·ÖÞ¹ÉÖ¸ÊÕÅÌÉÏÕÇ£¬·¨¹ú CAC-40 Ö¸ÊýÊÕºì 0.8%¡£Ó¢¹ú FTSE-100 Ö¸Êý¿´ÕÇ 0.2%£¬µÂ¹ú DAX Ö¸ÊýÑïÉý 0.5%¡£
ÑǹÉÊÕÅÌÕðµ´ÕûÀí£¬ÉϺ£×ÛºÏÖ¸Êý´ìµÍ 1.9%£¬Ïã¸ÛºãÉúÖ¸Êýϵø 2.0%£¬ÈÕ±¾ÈÕ¾Ö¸ÊýÊÕºì 0.2%¡£
ÃÀÔªºÍÉÌÆ·£ºÃÀÔª¶ÒËùÓÐÖ÷Òª»õ±Ò¾ù³Êϵø£¬°üÀ¨Å·Ôª¡¢Ó¢°÷ºÍÈÕÔªÔÚÄÚ¡£
12 Ô½»¸îµÄÔÓÍÆÚ»õ¼Û¸ñ´ìµÍ 1.90 ÃÀÔª»ò 2.3% ÖÁÿͰ 80.44 ÃÀÔª¡£
12 Ô COMEX ÆÚ½ð¼Û¸ñ´ìµÍ 1.50 ÃÀÔª»ò 0.1%£¬ÊÕ±¨Ã¿°»Ë¾ 1336.90 ÃÀÔª
¹«Õ®£º10 ÄêÆÚ»ù×¼¹«Õ®¼Û¸ñÊÕÅÌÏ»¬£¬¹«Õ®Ö³ÀûÂÊÓÉ×òÈÕ 2.85% ΢ÉýÖÁ 2.86%¡£¹«Õ®¼Û¸ñÓëÖ³ÀûÂÊϵ³Ê·´Ïò×ßÊÆ¡£
Å·¹ÉÅ̺ó©¤Ò½Ò©¹ÉÉÏÕÇ ´ø¶¯´óÅÌÊÕ¸ß0.5%
Å·ÖÞ¹ÉÊÐÖÜÈýÉÏÕÇ£¬ÊÕ¸´×òÈÕ²¿·ÝµÄµø·ù¡£×òÈÕÅ·ÃËÓë¹ú¼Ê»õ±Ò»ù½ð¹ÙÔ±Ðû²¼Óë°®¶ûÀ¼½øÐÐ̸ÅУ¬Ä¿±êÔÚ¾ö¶¨ÌṩԮÖúµÄ×î¼Ñ·½Ê½£¬¹ÉÊдó·ùϵø¡£
Å·ÖÞStoxx 600Ö¸ÊýÉÏÕÇ0.5%£¬ÊÕÓÚ267.31µã¡£
Ò½Ò©¹ÉΪ±íÏÖ×î¼ÑÀà¹ÉÖ®Ò»£¬Roche Holding (CH:ROG)Ðû²¼Ï÷¼õ³É±¾¼Æ»®£¬GlaxoSmithKline (UK:GSK)Ò»ÖÖÒ©Æ·»ñµÃ¿Ï¶¨£¬´øÀ´Àû¶à¡£
·¨¹úCAC-40Ö¸ÊýÉÏÕÇ0.8%ÖÁ3792.35£¬´óÐÍÒøÐм¯ÍÅSociete Generale (FR:GLE)ÉÏÕÇ2%¡£
µÂ¹úDAX-30Ö¸ÊýÊÕ¸ß0.6%ÖÁ6700.07¡£
Ó¢¹úFTSE-100Ö¸ÊýÉÏÕÇ0.2%ÖÁ5692.56¡£Experian (UK:EXPN)¹É¼ÛÉÏÕÇÓâ6%¡£¸ÃÐÅÏ¢·þÎñ¹«Ë¾¹«²¼ÉÏ°ëÄê»ñÀûÉÏÉý£¬²¢µ÷¸ß¹ÉÀû29%¡£
Å·ÖÞÖܱ߹ú¼Ò¹ÉÊÐÒàÉÏÕÇ¡£°®¶ûÀ¼ISEQÖ¸ÊýÉÏÕÇ1.5%¡£
Å·ÖÞÑëÐУ¬¹ú¼Ê»õ±Ò»ù½ðÓëÅ·Ã˹ÙÔ±½«Óë°®¶ûÀ¼½øÐдèÉÌ£¬ÌÖÂÛÌṩç£À§£¬½â¾öÊг¡·çÏÕµÄ×î¼Ñ·½Ê½£¬ÓÈÆäÊÇÕë¶Ô°®¶ûÀ¼ÒøÐÐÒµ¡£
·ÖÎöʦ˵Ͷ×ÊÈ˽¹µãÔÚÅ·ÔªÇøÊг¡ÓëÃÀ¹ú¾¼Ã¸´ËÕÆ£ÈõÖ®¼äÀ´»Ø°Úµ´£¬ÕâÖÖÇ÷Êƽ«½øÒ»²½³ÖÐø¡£ÃÀ¹úÓëÅ·Ö޵ij¤ÆڽṹÐÔÎÊÌâ¼°ÓÐÏ޶ȵijɳ¤£¬½«ÄÑÒÔ±ÜÃâ¡£
ÔÚÂ׶أ¬GlaxoSmithKline¹É¼ÛÉÏÕÇ2.4%£¬ÃÀ¹úʳƷҩÎï¹ÜÀí¾Ö(FDA)һίԱ»á½¨ÒéºË×¼GlaxoÓëHuman Genome¿Æ¼¼¹«Ë¾ÁªºÏ¿ª·¢µÄÖÎÀÇ´¯Ò©ÎïLupus£¬ÎªÀû¶à¡£
´óÒ©³§Roche¹É¼ÛÉÏÕÇ1.3%¡£¸Ã¹«Ë¾Ëµ½«²ÃÔ±4800ÈË£¬»òÔ±¹¤ÈËÊýµÄ6%¡£Ô¤ÆÚÕâÏî²ÃÔ±¼°ÆäËüÌáÉýЧÂÊ´ëʩÿÄê¿É½ÚÊ¡24ÒÚÈðÊ¿·¨ÀÊ¡£
Ôڵ¹ú£¬Infineon Technologies (DE:IFX)ÉÏÕÇ1.4%£¬À©´ó×òÈÕÇ¿¾¢µÄÕÇÊÆ¡£Ê®ÄêÀ´£¬¸Ã¼¯ÍÅÊ׶Ⱦö¶¨·¢·Å¹ÉÀû¡£
ŦԼ»ãÊЩ¤Êý¾ÝÆ£ÈõÇ¿»¯Fed¹ºÂòծȯ¼Æ»® ÃÀԪϵø
ÃÀÔª¶ÒÅ·ÔªÈýÌìÀ´Ê׶Èϵø¡£¾¼ÃÊý¾Ý½ÏÔ¤ÆÚÆ£Èõ£¬´ÙʹͶ×ÊÈ˸ü¼ÓÔ¤ÆÚÁª°î×¼±¸ÀíÊ»á(Fed)½«Ö´ÐйºÂò6000ÒÚÃÀÔª¼Æ»®£¬Ñ¹µÍÃÀÔª¡£
ÃÀÔª¶Ò´ó¶àÍâ±Òϵø£¬Ò»·Ý±¨¸æÏÔʾ£¬¿Û³ýʳƷÓëÄÜÔ´£¬ÃÀ¹ú10ÔÂÏû·ÑÕßÎï¼ÛÖ¸Êý´´×îµÍÉÏÉýÄêÂÊ£¬¶ÔÃÀÔª¹¹³ÉѹÁ¦¡£Å·ÖÞÖ§³ÖÕ®Îñ²øÉíµÄ°®¶ûÀ¼µÄ̸ÅУ¬Îȶ¨ÁËÊг¡£¬Å·ÔªÒò¶øÉÏÕÇ¡£
·ÖÎöʦ˵£¬FedÊÇ·ñÂò½øÈ«²¿µÄ6000ÒÚÃÀԪծȯ£¬Êг¡ÕùÂÛ²»ÒÑ¡£½ñÈÕµÄÊý¾Ý½áÊøÁËÕâÏîÕùÂÛ£¬ÃÀÔªÒò¶øÔÙ¶ÈÆ£Èõ¡£
±±¾©Ê±¼ä03:40 ÃÀԪϵø0.2%ÖÁ1.3520ÃÀÔª¶Ò1Å·Ôª¡£ÃÀÔª±¨83.31ÈÕÔª£¬ÉÙÓб䶯¡£Å·ÔªÉÏÕÇ0.2%ÖÁ112.61ÈÕÔª¡£
ÖÁÃ÷Äê6Ô£¬FedÿÔ½«Âò½ø750ÒÚÃÀԪծȯ£¬´Ì¼¤¾ÍÒµÓëͨ»õÅòÕÍ¡£½ñÄê3ÔÂΪֹ£¬FedÒÑÂò½ø1.7Õ×¹«Õ®ÓëµÖѺ´û¿îµ£±£Õ®È¯¡£
Fed×î½üÒ»²¨µÄÂò½ø¼Æ»®£¬ÒýÀ´ÁËÃÀ¹úÓëÍâ¹úµÄÇ¿ÁÒÅê»÷¡£µÂ¹ú²Æ³¤Schaeuble±íʾ£¬ÕâÏî¼Æ»®Ä¿µÄÔÚʹÃÀÔª±áÖµ£¬¹²ºÍµ³ÔÚ¹ú»áµÄËÄλÁìÐä½ñÈÕÖº¯²®ÄÏ¿Ë£¬±í´ï¡¸¸ß¶Èµ£ÓÇ¡¹£¬ÐÅÖÐÖ¸³ö¡¸ÕâÏî¼Æ»®ÎªÃÀԪδÀ´µÄÇ¿ÊÆ´øÀ´ÖØ´ó²»È·¶¨ÐÔ¡£¡¹
ÃÀ¹ú½ñÈÕ¹«²¼£¬¿Û³ýʳƷÓëÄÜÔ´£¬ÃÀ¹ú10ÔÂÏû·ÑÕßÎï¼ÛÖ¸Êý½ÏÈ¥ÄêͬÆÚÉÏÉý0.6%£¬´´1958ÄêÒÔÀ´×îµÍÄêÂÊÉý·ù£¬¸Ã±¨¸æ¹«²¼ºó£¬ÃÀÔª¶ÒÅ·ÔªÓë¶ÒÈÕÔªÉÔÔçÕÇÊÆ·´×ª¡£
½ñÔ磬ŷԪ¶ÒÃÀÔª½Ó½üÆßÖܵ͵㣬Ͷ×ÊÈ˵£ÓÇ°®¶ûÀ¼Èôδ»ñµÃç£À§¼Æ»®£¬ÆäÒøÐÐΣ»ú½«À©É¢ÖÁÅ·ÃËÆäËü»áÔ±¹ú¡£
Å·ÃËÒÑ¿ªÊ¼Õë¶Ô°®¶ûÀ¼Õ®Îñ²øÉíµÄÒøÐÐÒµ£¬ÑÐÄâ³öÒ»Ì׿ÉÄܵÄç£À§¼Æ»®¡£Å·ÃËÓë¹ú¼Ê»õ±Ò»ù½ðµÄר¼ÒÃ÷ÈÕ½«¿ªÊ¼¼ì²éÕâЩÒøÐеÄÕÊÄ¿¡£
Å·ÔªÇø16¹ú²Æ³¤Ëµ£¬¼¯ÌåÆÀ¹À½«¾ö¶¨°®¶ûÀ¼ÊÇ·ñÄÜ×ÔÐд¦ÀíÒøÐÐÌåϵÎÊÌ⣬»òÐèÒªÒÀÀµÅ·ÃËÓë¹ú¼Ê»õ±Ò»ù½ðµÄ750ÒÚÅ·Ôªç£À§»ù½ð¡£
·ÖÎöʦ˵£¬Å·ÖÞ¹ÙÔ±µÄ̸»°£¬¼°Å·ÃËÓëIMF¹ÙÔ±·ÃÎÊ°®¶ûÀ¼£¬Ê¹µÃÊг¡°²ÐÄÒ»µã¡£µ«Å·Ôª¶ÒÃÀÔª½ñÈÕËä·´µ¯£¬Ñ¹Á¦Ô¤ÆÚÈÔ½«³ÖÐø¡£
ŦԼծÊСª¹«Õ®¼Û¸ñÏ»¬,QE2ÃüÔ˵IJ»È·¶¨ÐԸǹý¾¼ÃÊý¾ÝµÄÓ°Ïì
* ¹«Õ®¼Û¸ñĨȥÕÇ·ù,Òò¹²ºÍµ³Ö¸ÔðQE2
* κÍͨÕͺÍÆ£Èõ·¿ÊÐÊý¾Ý¶ÌÔÝÍƸ߹«Õ®¼Û¸ñ
* һЩͶ×ÊÕßÈÔÑ°Çó½â³ýѺעQE2µÄ²Öλ
ÃÀ¹ú¹«Õ®¼Û¸ñÖÜÈýβÅÌÔâÅ×ÊÛ¶øÏ»¬,ÒòÃÀÁª´¢(FED)ÐÂÒ»ÂÖ¿íËÉÕþ²ß(QE2)ÃüÔ˵IJ»È·¶¨ÐÔ,¸Ç¹ýÁ˾¼ÃÊý¾ÝµÄÓ°Ïì.
ÔÚÏÂÖÜÐÂÕ®±êÊÛÇ°,½»Ò×É̺ÍͶ×ÊÕßÑ°Çó³öÍѶàÍ·Í·´çÒÔ¼°½áÇå²Öλ,ÔöÌíÁ˹«Õ®Êг¡µÄ¸ºÃæѹÁ¦.
¶ÔÃÀÁª´¢6,000ÒÚÃÀÔªÃÀ¹ú¹«Õ®¹ºÂò¼Æ»®µÄ·´¶ÔÖ®ÉùÉýÎÂ,һȺÖ÷Òª¹²ºÍµ³ÒéÔ±¹«²¼ÁËÒ»·Ý·¢¸øÃÀÁª´¢Ö÷ϯ±´ÄϿ˵ÄÐżþ,ÐÅÖÐÖ¸ÔðÃÀÁª´¢µÄµÚ¶þÂÖÁ¿»¯¿íËɼƻ®ÓпÉÄÜ»á´òѹÃÀÔªºÍ¼¤·¢Í¨ÕÍ.
ÄÜÔ´Å̺󩤵£ÓÇÐèÇó²»¼Ñ ÔÓÍÊÕµÍ1.90ÃÀÔª
ÔÓÍÆÚ»õÖÜÈýϵøÖÁ½üÒ»¸öÔµ͵㣬ÃÀ¹ú¹«²¼ÉÏÖÜÔÓÍÓëÆûÓÍ¿â´æÒâÍâϽµ£¬²¢Î´ÄÜÏû³ýÈ«ÇòÔÓÍÐèÇóµÄµ£ÓÇ¡£
12ÔÂÔÓÍÊÕµÍ1.90ÃÀÔª£¬»ò2.3%£¬ÖÁÿͰ80.44ÃÀÔª¡£Â׶ز¼Â×ÌØÔÓÍϵø1.44ÃÀÔªÖÁÿͰ83.29ÃÀÔª¡£
µ£ÓÇÖйúÖÂÁ¦ÀäÈ´¾¼Ã¼°Å·ÖÞÖ÷ȨծÎñÎÊÌ⣬ʹµÃÔÓͼ۸ñÁ¬ÐøµÚËÄÌìϵø£¬ÅÌÖÐϵøÖÁÿͰ80.06ÃÀÔªµÍµã¡£Ô¤ÆÚÖйú´ó½½«ÉýÏ¢£¬×èֹͨ»õÅòÕÍ£¬´ËÒ»¿ÉÄÜÐÔÒÑÊýÈÕ¶ÔÔÓÍÓëÆäËüÉÌÆ·¹¹³ÉѹÁ¦¡£
ÉÏÖÜ£¬¹ÈÎïÓë½ðÊôÊг¡×ÔÊýÄê¸ßµã»Øµµ£¬ÔÓÍÒà×Ô¶þÄê¸ßµãϵø£¬Í¶×ÊÈ˵£ÓÇÖйú´ó½Êг¡¶ÔÔÁÏÐèÇó£¬ÎªÀû¿Õ¡£
·ÖÎöʦ˵£¬ÉÏÖÜ×îÖØÒªµÄÒòËØ£¬ÔÚÓÚµ£ÓÇÖйú´ó½¿ÉÄÜÉýÏ¢£¬ÒÔ¼õ»º¾¼Ã³É³¤¡£ÖйúΪȫÇò×î´óÄÜÔ´Ïû·Ñ¹ú£¬µÚ¶þ´óÔÓÍÏû·Ñ¹ú¡£
ÔÚÃÀ¹ú£¬11ÔÂ12ÈÕ½áÊøµÄÒ»ÖÜ£¬ÔÓÍ¿â´æ¼õÉÙ730ÍòÍ°£¬´´15¸öÔÂÀ´×î´ó¼õ·ù¡£
¸Ã±¨¸æ¹«²¼ºó£¬ÔÓÍÒ»¶È·´µ¯ÉÏÑµ«Òò¿â´æ¼õÉÙÖ÷ÒªÔÒòÔÚÓÚ½ø¿Ú¼õÉÙ£¬ÏÔʾ¸ß¿â´æÓëκ͵ÄÐèÇ󣬳ÖÐøΪÃÀ¹úÊг¡Ñ¹Á¦¡£
·ÖÎöʦ˵£¬ÔÓÍ¿â´æ´ó·ùϽµ£¬ÊÇÒòÁ¶Óͳ§ÂòÅ̲»¼Ñ£¬Æä¶ÔÊг¡Ö§³Å²¢²»Ã÷ÏÔ¡£Ä«Î÷¸çÍåÑØ°¶¿â´æϽµ£¬ÊÇÒò½ø¿Ú·Ç³£µÍ£¬Òâζ¸ü¶àÔÓÍÈ¥ÁËÍâ¹úÊг¡¡£
ÃÀ¹úÔÓÍÓëȼÁÏÓÍ¿â´æÈÔ¸ßÓÚÎåÄêƽ¾ùˮƽ¡£9Ô£¬ÔÓÍÓëÔÓͲúÆ·¿â´æ´¥¼°27Äê¸ßµã¡£
¸Ã±¨¸æ²¢ÏÔʾ£¬ÆäËüȼÁϲúÆ·¿â´æÒàϽµ£¬ÆûÓÍ¿â´æ¼õÉÙ270ÍòÍ°£¬ÕôÁóÓÍ¿â´æ--°üÀ¨ÈÈȼÓÍÓë²ñÓÍ--¼õÉÙ110ÍòÍ°¡£
·ÖÎöʦԤ¹À£¬ÆûÓÍ¿â´æΪ¼õÉÙ60ÍòÍ°£¬ÕôÁóÓÍ¿â´æ¼õÉÙ220ÍòÍ°¡£
12ÔÂÐÂÅä·½ÆûÓÍÊÕ¸ß0.22ÃÀ·ÖÖÁÿ¼ÓÂØ2.1579ÃÀÔª£¬12ÔÂÈÈȼÓÍÊÕµÍ5.71ÃÀ·ÖÖÁÿ¼ÓÂØ2.2519ÃÀÔª¡£
ÃâÔðÉùÃ÷£ºÉÏÎĽö´ú±í×÷Õß»ò·¢²¼Õ߹۵㣬Óë±¾Õ¾Î޹ء£±¾Õ¾²¢ÎÞÒåÎñ¶ÔÆäÔ´´ÐÔ¼°ÄÚÈݼÓÒÔ֤ʵ¡£¶Ô±¾ÎÄÈ«²¿»òÕß²¿·ÖÄÚÈÝ(ÎÄ×Ö»òͼƬ)µÄÕæʵÐÔ¡¢ÍêÕûÐÔ±¾Õ¾²»×÷Èκα£Ö¤»ò³Ðŵ£¬Çë¶ÁÕ߲ο¼Ê±×ÔÐкËʵÏà¹ØÄÚÈÝ¡£±¾Õ¾ÖÆ×÷¡¢×ªÔØ¡¢Í¬Òâ»áÔ±·¢²¼ÉÏÊöÄÚÈݽö³öÓÚ´«µÝ¸ü¶àÐÅϢ֮ĿµÄ£¬µ«²»±íÃ÷±¾Õ¾ÈÏ¿É¡¢Í¬Òâ»òÔÞͬÆä¹Ûµã¡£ÉÏÊöÄÚÈݽö¹©²Î¿¼£¬²»¹¹³ÉͶ×ʾö²ßÖ®½¨Ò飻Ͷ×ÊÕ߾ݴ˲Ù×÷£¬·çÏÕ×Ôµ£¡£Èç¶ÔÉÏÊöÄÚÈÝÓÐÈκÎÒìÒ飬ÇëÁªÏµÏà¹Ø×÷Õß»òÓë±¾Õ¾Õ¾³¤ÁªÏµ£¬±¾Õ¾½«¾¡¿ÉÄÜÐÖú´¦ÀíÓйØÊÂÒË¡£Ð»Ð»·ÃÎÊÓëºÏ×÷£¡ ÖÐÎÙÔÚÏ߲ɼ¯ÖÆ×÷.
|